Perrigo | PRGO - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.53B 4.47B 2026-03
Abbott USD 25.51B 488M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Dr.Reddys Laboratories INR 301.79B 4.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
J&J USD 59.17B 3.55B 2026-03
Merck USD 35.02B 8.5B 2026-03
Nestle CHF 31.97B 1.46B 2025-12
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi EUR 30.16B 789M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03
Zoetis USD 6.47B 294M 2026-03